Cibc World Market Inc. raised its position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 6,976.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 392,201 shares of the medical equipment provider's stock after acquiring an additional 386,659 shares during the period. Cibc World Market Inc. owned approximately 0.55% of Align Technology worth $51,998,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. K.J. Harrison & Partners Inc bought a new position in shares of Align Technology in the second quarter worth $1,872,000. Maridea Wealth Management LLC bought a new stake in shares of Align Technology during the second quarter valued at about $1,659,000. NewEdge Wealth LLC acquired a new stake in Align Technology in the second quarter worth about $1,658,000. Pallas Capital Advisors LLC acquired a new stake in Align Technology in the second quarter worth about $1,128,000. Finally, IFP Advisors Inc lifted its holdings in Align Technology by 8,055.0% in the third quarter. IFP Advisors Inc now owns 57,085 shares of the medical equipment provider's stock worth $7,561,000 after purchasing an additional 56,385 shares during the period. 88.43% of the stock is currently owned by institutional investors and hedge funds.
Align Technology Trading Down 1.5%
Shares of ALGN opened at $163.46 on Wednesday. The business's 50-day moving average price is $152.02 and its 200 day moving average price is $168.57. The stock has a market capitalization of $11.52 billion, a P/E ratio of 23.79, a P/E/G ratio of 2.15 and a beta of 1.74. Align Technology, Inc. has a 1-year low of $130.23 and a 1-year high of $200.43.
Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. During the same period in the prior year, the firm earned $2.61 earnings per share. The business's quarterly revenue was up 1.9% on a year-over-year basis. On average, research analysts predict that Align Technology, Inc. will post 9.21 earnings per share for the current year.
Analysts Set New Price Targets
A number of research analysts recently commented on the stock. Stifel Nicolaus lowered their price objective on shares of Align Technology from $210.00 to $175.00 and set a "buy" rating on the stock in a research note on Friday, October 9th. Evercore downgraded Align Technology from an "outperform" rating to an "in-line" rating and set a $155.00 target price for the company. in a research report on Monday, October 5th. Wall Street Zen lowered Align Technology from a "buy" rating to a "hold" rating in a research note on Saturday, October 24th. Raymond James Financial reiterated a "buy" rating on shares of Align Technology in a research report on Monday, October 5th. Finally, Zacks Research raised Align Technology from a "strong sell" rating to a "hold" rating in a research note on Friday, November 13th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $193.08.
Check Out Our Latest Stock Report on Align Technology
Align Technology Company Profile
(
Free Report)
Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
Featured Articles
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Align Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.
While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.